RACK1 predicts poor prognosis and regulates progression of esophageal squamous cell carcinoma through its epithelial-mesenchymal transition

References

• Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011; 61:69–90; PMID:21296855
   PubMed Web of Science ®Google Scholar
• Mochly-Rosen D, Khaner H, Lopez J. Identification of intracellular receptor proteins for activated protein kinase C. Proc Natl Acad Sci U S A 1991; 88:3997–4000; PMID:1850844; http://dx.doi.org/10.1073/pnas.88.9.3997
   PubMed Web of Science ®Google Scholar
• Ron D, Chen CH, Caldwell J, Jamieson L, Orr E, Mochly-Rosen D. Cloning of an intracellular receptor for protein kinase C: a homolog of the beta subunit of G proteins. Proc Natl Acad Sci U S A 1994; 91:839–43; PMID:8302854; http://dx.doi.org/10.1073/pnas.91.3.839
   PubMed Web of Science ®Google Scholar
• Adams DR, Ron D, Kiely PA. RACK1, A multifaceted scaffolding protein: Structure and function. Cell Commun Signal 2011; 9:22; PMID:21978545; http://dx.doi.org/10.1186/1478-811X-9-22
   PubMed Web of Science ®Google Scholar
• Vomastek T, Iwanicki MP, Schaeffer HJ, Tarcsafalvi A, Parsons JT, Weber MJ. RACK1 targets the extracellular signal-regulated kinase/mitogen-activated protein kinase pathway to link integrin engagement with focal adhesion disassembly and cell motility. Mol Cell Biol 2007; 27:8296–305; PMID:17908799; http://dx.doi.org/10.1128/MCB.00598-07
   PubMed Web of Science ®Google Scholar
• Mamidipudi V, Zhang J, Lee KC, Cartwright CA. RACK1 regulates G1/S progression by suppressing Src kinase activity. Mol Cell Biol 2004; 24:6788–98; PMID:15254245; http://dx.doi.org/10.1128/MCB.24.15.6788-6798.2004
   PubMed Web of Science ®Google Scholar
• Mamidipudi V, Chang BY, Harte RA, Lee KC, Cartwright CA. RACK1 inhibits the serum- and anchorage-independent growth of v-Src transformed cells. FEBS Lett 2004; 567:321–6; PMID:15178345; http://dx.doi.org/10.1016/j.febslet.2004.03.125
   PubMed Web of Science ®Google Scholar
• Steele MR, McCahill A, Thompson DS, MacKenzie C, Isaacs NW, Houslay MD, Bolger GB. Identification of a surface on the beta-propeller protein RACK1 that interacts with the cAMP-specific phosphodiesterase PDE4D5. Cell Signal 2001; 13:507–13; PMID:11516626; http://dx.doi.org/10.1016/S0898-6568(01)00167-X
   PubMed Web of Science ®Google Scholar
• Bolger GB, McCahill A, Yarwood SJ, Steele MR, Warwicker J, Houslay MD. Delineation of RAID1, the RACK1 interaction domain located within the unique N-terminal region of the cAMP-specific phosphodiesterase, PDE4D5. BMC Biochem 2002; 3:24; PMID:12193273; http://dx.doi.org/10.1186/1471-2091-3-24
   PubMed Web of Science ®Google Scholar
• Wang Z, Zhang B, Jiang L, Zeng X, Chen Y, Feng X, Guo Y, Chen Q. RACK1, an excellent predictor for poor clinical outcome in oral squamous carcinoma, similar to Ki67. Eur J Cancer 2009; 45:490–6; PMID:19087901; http://dx.doi.org/10.1016/j.ejca.2008.11.012
   PubMed Web of Science ®Google Scholar
• Cao XX, Xu JD, Liu XL, Xu JW, Wang WJ, Li QQ, Chen Q, Xu ZD, Liu XP. RACK1: a superior independent predictor for poor clinical outcome in breast cancer. Int J Cancer 2010; 127:1172–9; PMID:20020495; http://dx.doi.org/10.1002/ijc.25120
   PubMed Web of Science ®Google Scholar
• Zhong X, Li M, Nie B, Wu F, Zhang L, Wang E, Han Y. Overexpressions of RACK1 and CD147 associated with poor prognosis in stage T1 pulmonary adenocarcinoma. Ann Surg Oncol 2013; 20:1044–52; PMID:22592183; http://dx.doi.org/10.1245/s10434-012-2377-4
   PubMed Web of Science ®Google Scholar
• Wu J, Meng J, Du Y, Huang Y, Jin Y, Zhang J, Wang B, Zhang Y, Sun M, Tang J. RACK1 promotes the proliferation, migration and invasion capacity of mouse hepatocellular carcinoma cell line in vitro probably by PI3K/Rac1 signaling pathway. Biomed Pharmacother 2013; 67:313–9; PMID:23582786; http://dx.doi.org/10.1016/j.biopha.2013.01.011
   PubMed Web of Science ®Google Scholar
• Ruan Y, Sun L, Hao Y, Wang L, Xu J, Zhang W, Xie J, Guo L, Zhou L, Yun X, et al. Ribosomal RACK1 promotes chemoresistance and growth in human hepatocellular carcinoma. J Clin Invest 2012; 122:2554–66; PMID:22653060; http://dx.doi.org/10.1172/JCI58488
   PubMed Web of Science ®Google Scholar
• Cao XX, Xu JD, Xu JW, Liu XL, Cheng YY, Wang WJ, Li QQ, Chen Q, Xu ZD, Liu XP. RACK1 promotes breast carcinoma proliferation and invasion/metastasis in vitro and in vivo. Breast Cancer Res Treat 2010; 123:375–86; PMID:19946739; http://dx.doi.org/10.1007/s10549-009-0657-x
   PubMed Web of Science ®Google Scholar
• Shen F, Yan C, Liu M, Feng Y, Chen Y. RACK1 promotes prostate cancer cell proliferation, invasion and metastasis. Mol Med Rep 2013; 8:999–1004; PMID:23912224
   PubMed Web of Science ®Google Scholar
• Hu F, Tao Z, Wang M, Li G, Zhang Y, Zhong H, Xiao H, Xie X, Ju M. RACK1 promoted the growth and migration of the cancer cells in the progression of esophageal squamous cell carcinoma. Tumour Biol 2013; 34(6):3893–9; PMID:23893384
   PubMed Web of Science ®Google Scholar
• Johann DJ Jr., McGuigan MD, Patel AR, Tomov S, Ross S, Conrads TP, Veenstra TD, Fishman DA, Whiteley GR, Petricoin EF 3rd, et al. Clinical proteomics and biomarker discovery. Ann N Y Acad Sci 2004; 1022:295–305; PMID:15251975; http://dx.doi.org/10.1196/annals.1318.045
   PubMed Web of Science ®Google Scholar
• Shi S, Deng YZ, Zhao JS, Ji XD, Shi J, Feng YX, Li G, Li JJ, Zhu D, Koeffler HP, et al. RACK1 promotes non-small-cell lung cancer tumorigenicity through activating sonic hedgehog signaling pathway. J Biol Chem 2012; 287:7845–58; PMID:22262830; http://dx.doi.org/10.1074/jbc.M111.315416
   PubMed Web of Science ®Google Scholar
• Guo Y, Wang W, Wang J, Feng J, Wang Q, Jin J, Lv M, Li X, Li Y, Ma Y, et al. Receptor for activated C kinase 1 promotes hepatocellular carcinoma growth by enhancing mitogen-activated protein kinase kinase 7 activity. Hepatology 2013; 57:140–51; PMID:22903704; http://dx.doi.org/10.1002/hep.25978
   PubMed Web of Science ®Google Scholar
• Deng YZ, Yao F, Li JJ, Mao ZF, Hu PT, Long LY, Li G, Ji XD, Shi S, Guan DX, et al. RACK1 suppresses gastric tumorigenesis by stabilizing the beta-catenin destruction complex. Gastroenterology 2012; 142:812-23 e15; PMID:22240482; http://dx.doi.org/10.1053/j.gastro.2011.12.046
   PubMed Web of Science ®Google Scholar
• Mamidipudi V, Dhillon NK, Parman T, Miller LD, Lee KC, Cartwright CA. RACK1 inhibits colonic cell growth by regulating Src activity at cell cycle checkpoints. Oncogene 2007; 26:2914–24; PMID:17072338; http://dx.doi.org/10.1038/sj.onc.1210091
   PubMed Web of Science ®Google Scholar
• Cao XX, Xu JD, Xu JW, Liu XL, Cheng YY, Li QQ, Xu ZD, Liu XP. RACK1 promotes breast carcinoma migration/metastasis via activation of the RhoA/Rho kinase pathway. Breast Cancer Res Treat 2011; 126:555–63; PMID:20499158; http://dx.doi.org/10.1007/s10549-010-0955-3
   PubMed Web of Science ®Google Scholar
• Kiely PA, Baillie GS, Lynch MJ, Houslay MD, O'Connor R. Tyrosine 302 in RACK1 is essential for insulin-like growth factor-I-mediated competitive binding of PP2A and beta1 integrin and for tumor cell proliferation and migration. The J Biol Chem 2008; 283:22952–61; PMID:18567578; http://dx.doi.org/10.1074/jbc.M800802200
   PubMed Web of Science ®Google Scholar
• Serrels B, Sandilands E, Serrels A, Baillie G, Houslay MD, Brunton VG, Canel M, Machesky LM, Anderson KI, Frame MC. A complex between FAK, RACK1, and PDE4D5 controls spreading initiation and cancer cell polarity. Curr Biol 2010; 20:1086–92; PMID:20493699 10.1016/j.cub.2010.04.042
   PubMed Web of Science ®Google Scholar